Cellnovo Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
92
- Latest Deal Type
-
Liquidation
Cellnovo General Information
Description
Cellnovo Group SA is engaged in the development of a system for diabetes management. The product portfolio includes cordless micro-pump, an integrated monitoring device and a cellular handset with a touch screen with an embedded blood glucose meter.
Contact Information
Website
www.cellnovo.comCorporate Office
- 6, rue de Téhéran
- 75008 Paris
- France
Corporate Office
- 6, rue de Téhéran
- 75008 Paris
- France
Cellnovo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 26-Apr-2019 | Completed | Bankruptcy: Liquidation | |||
| 9. Debt - General | 01-Aug-2018 | Completed | ||||
| 8. PIPE | 31-Jul-2018 | Completed | Generating Revenue | |||
| 7. Debt - General | 07-Jul-2017 | Completed | ||||
| 6. PIPE | 07-Jul-2017 | Completed | Generating Revenue | |||
| 5. Debt - General | 01-May-2017 | Completed | ||||
| 4. IPO | 10-Jul-2015 | Completed | Generating Revenue | |||
| 3. Debt - General | 01-Jul-2015 | Completed | ||||
| 2. Later Stage VC (Series B) | 21-Mar-2013 | $45.8M | $45.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | Completed | Startup |
Cellnovo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B1 | ||||||||
| Series A | 8,103,333 | $1.51 | $1.51 | $1.51 | 4.07% |
Cellnovo Patents
Cellnovo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201401586-D0 | Actuator and actuation method | Active | 30-Jan-2014 | ||
| GB-2525838-A | Actuator and actuation method | Active | 30-Jan-2014 | ||
| WO-2015114374-A1 | Actuator and actuation method | Inactive | 30-Jan-2014 | ||
| EP-3100188-A1 | Handset device | Active | 30-Jan-2014 | ||
| EP-3100188-B1 | Handset device | Active | 30-Jan-2014 | H04W52/0209 |
Cellnovo Signals
Cellnovo Investments (1)
Cellnovo’s most recent deal was a Corporate Asset Purchase with TypeZero (Artificial Pancreas Technology). The deal was made on 18-Apr-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TypeZero (Artificial Pancreas Technology) | 18-Apr-2017 | Corporate Asset Purchase | Buildings and Property |
Cellnovo FAQs
-
When was Cellnovo founded?
Cellnovo was founded in 2002.
-
Where is Cellnovo headquartered?
Cellnovo is headquartered in Paris, France.
-
What is the size of Cellnovo?
Cellnovo has 92 total employees.
-
What industry is Cellnovo in?
Cellnovo’s primary industry is Monitoring Equipment.
-
Is Cellnovo a private or public company?
Cellnovo is a Private company.
-
What is Cellnovo’s current revenue?
The current revenue for Cellnovo is .
-
How much funding has Cellnovo raised over time?
Cellnovo has raised $147M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process